Science Explorer Interactive view Map
Company · Belfast · United Kingdom

Celerion (United Kingdom)

celerion.comROR OpenAlex
Research works
12
▲ 603% vs 2013–17
Citations
174
14.1 per fractional work
Top-10% rate
39.1%
record average 16.5%
Open access
52%
world 28%

Not ranked overall: Celerion (United Kingdom) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Biochemistry, Genetics and Molecular Biology: 0.76× its world share, 0 worksBiochemistry, Geneti…Immunology and Microbiology: 0.43× its world share, 0 worksImmunology and Micro…Pharmacology, Toxicology and Pharmaceutics: 43.60× its world share, 0 worksPharmacology, Toxico…Chemistry: 7.49× its world share, 0 worksChemistryComputer Science: 0.46× its world share, 0 worksComputer ScienceEngineering: 0.03× its world share, 0 worksEngineeringMedicine: 3.16× its world share, 2 worksMedicineEconomics, Econometrics and Finance: 1.69× its world share, 0 worksEconomics, Econometr…1×world share
more than its size predictsabout as predictedless

Rings at 0.5×, 1× and 2×. Widest outward: Pharmacology, Toxicology and Pharmaceutics, 43.6×. Every wedge is a field page.

Which research topics does Celerion (United Kingdom) publish most on?

By volume in 2022–2025: Pharmaceutical studies and practices, Pharmacological Effects of Natural Compounds, Intramuscular injections and effects and Drug-Induced Adverse Reactions.

Pharmaceutical studies and practices: 0 fractional worksPharmacological Effects of Natural Compounds: 0 fractional worksIntramuscular injections…0Intramuscular injections and effects: 0 fractional worksDrug-Induced Adverse Rea…0Drug-Induced Adverse Reactions: 0 fractional worksAnalytical Methods in Ph…0Analytical Methods in Pharmaceuticals: 0 fractional worksPharmacogenetics and Dru…0Pharmacogenetics and Drug Metabolism: 0 fractional worksSynthesis and Catalytic Reactions: 0 fractional worksDrug Transport and Resistance Mechanisms: 0 fractional worksComputational Drug Discovery Methods: 0 fractional worksAntibiotics Pharmacokinetics and Efficacy: 0 fractional works
Pediatrics, Perinatology and Child HealthPharmacologyEmergency MedicineAnalytical Chemistry3 others

Area is fractional works; colour is the subfield each topic belongs to.

  1. 1 Pharmaceutical studies and practices Pediatrics, Perinatology and Child Health 0 works
  2. 2 Pharmacological Effects of Natural Compounds Pharmacology 0 works
  3. 3 Intramuscular injections and effects Emergency Medicine 0 works
  4. 4 Drug-Induced Adverse Reactions Pharmacology 0 works
  5. 5 Analytical Methods in Pharmaceuticals Analytical Chemistry 0 works
  6. 6 Pharmacogenetics and Drug Metabolism Pharmacology 0 works
  7. 7 Synthesis and Catalytic Reactions Organic Chemistry 0 works
  8. 8 Drug Transport and Resistance Mechanisms Oncology 0 works
  9. 9 Computational Drug Discovery Methods Computational Theory and Mathematics 0 works
  10. 10 Antibiotics Pharmacokinetics and Efficacy Pharmacology 0 works

How open and international is its research?

Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available52.2%not open47.8%

World: 28% of research is openly available.

with international co-authors50.1%domestic only49.9%

World: 19% is written across borders.

How has Celerion (United Kingdom)'s research output changed?

Output in 2018–2022 was 603% higher than in 2013–2017.

2005201020152020
grewheldshrank

The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.

Other research institutions in Belfast

All research institutions in Belfast

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.